CYNTHIA COE: Open Payments
NPI 1528758463 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,405 in 148 payments from 19 companies in 2025. Trend: 2023 $1,305 · 2024 $2,939 · 2025 $3,405
Food & beverage: $3,405
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $604 |
| E.R. Squibb & Sons, L.L.C. | 13 | $523 |
| ABBVIE INC. | 17 | $452 |
| Otsuka America Pharmaceutical, Inc. | 12 | $300 |
| Alkermes, Inc. | 9 | $272 |
| Collegium Pharmaceutical, Inc. | 10 | $239 |
| Vanda Pharmaceuticals Inc. | 12 | $231 |
| Janssen Pharmaceuticals, Inc | 9 | $174 |
| Neurocrine BioSciences, Inc. | 12 | $163 |
| Corium, LLC | 9 | $90 |
Products named: CAPLYTA, COBENFY, VRAYLAR, REXULTI, Jornay PM, LYBALVI, FANAPT, INGREZZA.
Industry payments across FL — which companies pay providers there.
